Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2004 Dec;59(12):1016–1019. doi: 10.1136/thx.2003.020768

Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation

G Carpagnano 1, S Kharitonov 1, M Foschino-Barbaro 1, O Resta 1, E Gramiccioni 1, P Barnes 1
PMCID: PMC1746910  PMID: 15563698

Abstract

Background: Hyperoxia increases oxidative stress through the generation of reactive oxygen species and may therefore enhance inflammation in the lungs. The aim of this study was to investigate whether short term supplementary oxygen (28%) increases oxidative stress and inflammation in the airways by measuring 8-isoprostane and interleukin 6 (IL-6) concentrations in exhaled breath condensate.

Methods: Twenty three healthy subjects (12 men, mean (SD) age 48 (7) years) and 23 patients with chronic obstructive pulmonary disease (COPD; 15 men, mean (SD) age 56 (5) years) were studied. 8-isoprostane and IL-6 concentrations were measured by immunoassay.

Results: Increased concentrations of 8-isoprostane and IL-6 were found in all subjects after breathing 28% oxygen for 1 hour. In healthy subjects the concentrations of 8-isoprostane and IL-6 were 10.9 (2.9) pg/ml and 4.9 (0.8) pg/ml, respectively, compared with baseline concentrations of 6.1 (1.3) pg/ml and 2.9 (0.6) pg/ml, and in patients with COPD the concentrations were 27.9 (3.1) pg/ml and 8.3 (1.2) pg/ml), respectively, compared with baseline concentrations of 18.9 (3.6) pg/ml and 6.3 (0.6) pg/ml. By contrast, breathing air through the same face mask for 1 hour had no significant effects on 8-isoprostane or IL-6 concentrations in normal subjects or those with COPD.

Conclusions: These findings suggest that short term supplementary oxygen may enhance oxidative stress and inflammation in the airways. Whether this happens with long term oxygen therapy needs to be determined.

Full Text

The Full Text of this article is available as a PDF (75.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J. Chronic obstructive pulmonary disease. N Engl J Med. 2000 Jul 27;343(4):269–280. doi: 10.1056/NEJM200007273430407. [DOI] [PubMed] [Google Scholar]
  2. Bearden S. E., Cheuvront S. N., Ring T. A., Haymes E. M. Oxidative stress during a 3.5-hour exposure to 120 kPa(a) PO2 in human divers. Undersea Hyperb Med. 1999 Fall;26(3):159–164. [PubMed] [Google Scholar]
  3. Carpagnano Giovanna E., Kharitonov Sergei A., Resta Onofrio, Foschino-Barbaro Maria P., Gramiccioni Enzo, Barnes Peter J. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest. 2002 Oct;122(4):1162–1167. doi: 10.1378/chest.122.4.1162. [DOI] [PubMed] [Google Scholar]
  4. Chaouat A., Weitzenblum E., Kessler R., Charpentier C., Enrhart M., Schott R., Levi-Valensi P., Zielinski J., Delaunois L., Cornudella R. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J. 1999 Nov;14(5):1002–1008. doi: 10.1183/09031936.99.14510029. [DOI] [PubMed] [Google Scholar]
  5. Jatakanon A., Uasuf C., Maziak W., Lim S., Chung K. F., Barnes P. J. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1532–1539. doi: 10.1164/ajrccm.160.5.9806170. [DOI] [PubMed] [Google Scholar]
  6. Kharitonov S. A., Donnelly L. E., Montuschi P., Corradi M., Collins J. V., Barnes P. J. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax. 2002 Oct;57(10):889–896. doi: 10.1136/thorax.57.10.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mantell L. L., Lee P. J. Signal transduction pathways in hyperoxia-induced lung cell death. Mol Genet Metab. 2000 Sep-Oct;71(1-2):359–370. doi: 10.1006/mgme.2000.3046. [DOI] [PubMed] [Google Scholar]
  8. Montuschi P., Collins J. V., Ciabattoni G., Lazzeri N., Corradi M., Kharitonov S. A., Barnes P. J. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1175–1177. doi: 10.1164/ajrccm.162.3.2001063. [DOI] [PubMed] [Google Scholar]
  9. Morcillo E. J., Estrela J., Cortijo J. Oxidative stress and pulmonary inflammation: pharmacological intervention with antioxidants. Pharmacol Res. 1999 Nov;40(5):393–404. doi: 10.1006/phrs.1999.0549. [DOI] [PubMed] [Google Scholar]
  10. Phillips M., Cataneo R. N., Greenberg J., Grodman R., Gunawardena R., Naidu A. Effect of oxygen on breath markers of oxidative stress. Eur Respir J. 2003 Jan;21(1):48–51. doi: 10.1183/09031936.02.00053402. [DOI] [PubMed] [Google Scholar]
  11. Song W., Zhao J., Li Z. Interleukin-6 in bronchoalveolar lavage fluid from patients with COPD. Chin Med J (Engl) 2001 Nov;114(11):1140–1142. [PubMed] [Google Scholar]
  12. Tarpy S. P., Celli B. R. Long-term oxygen therapy. N Engl J Med. 1995 Sep 14;333(11):710–714. doi: 10.1056/NEJM199509143331107. [DOI] [PubMed] [Google Scholar]
  13. Vacchiano C. A., Osborne G. R., Tempel G. E. 8-ISO-PGF2alpha production by alveolar macrophages exposed to hyperoxia. Shock. 1998 Apr;9(4):266–273. doi: 10.1097/00024382-199804000-00006. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES